BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10666684)

  • 21. Developmental consequences of autosomal aneuploidy in mammals.
    Gearhart JD; Oster-Granite ML; Reeves RH; Coyle JT
    Dev Genet; 1987; 8(4):249-65. PubMed ID: 2971493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aneuploidy: from a physiological mechanism of variance to Down syndrome.
    Dierssen M; Herault Y; Estivill X
    Physiol Rev; 2009 Jul; 89(3):887-920. PubMed ID: 19584316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene dosage imbalance of human chromosome 21 in mouse embryonic stem cells differentiating to neurons.
    Wang CC; Kazuki Y; Oshimura M; Ikeo K; Gojobori T
    Gene; 2011 Aug; 481(2):93-101. PubMed ID: 21549184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards the understanding of Down syndrome using mouse models.
    Yamakawa K
    Congenit Anom (Kyoto); 2012 Jun; 52(2):67-71. PubMed ID: 22639990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human chromosome 21q22.2-qter carries a gene(s) responsible for downregulation of mlc2a and PEBP in Down syndrome model mice.
    Kazuki Y; Kimura M; Nishigaki R; Kai Y; Abe S; Okita C; Shirayoshi Y; Schulz TC; Tomizuka K; Hanaoka K; Inoue T; Oshimura M
    Biochem Biophys Res Commun; 2004 Apr; 317(2):491-9. PubMed ID: 15063784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mouse models of cognitive disabilities in trisomy 21 (Down syndrome).
    Roubertoux PL; Carlier M
    Am J Med Genet C Semin Med Genet; 2010 Nov; 154C(4):400-16. PubMed ID: 20981769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down syndrome mouse models are looking up.
    Reeves RH
    Trends Mol Med; 2006 Jun; 12(6):237-40. PubMed ID: 16677859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
    Rachidi M; Lopes C
    Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal balanced translocation (4;21) leading to an offspring with partial duplication of 4q and 21q without phenotypic manifestations of Down syndrome.
    El-Ruby M; Hemly NA; Zaki MS
    Genet Couns; 2007; 18(2):217-26. PubMed ID: 17710874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Models for Down syndrome: chromosome 21-specific genes in mice.
    Epstein CJ; Berger CN; Carlson EJ; Chan PH; Huang TT
    Prog Clin Biol Res; 1990; 360():215-32. PubMed ID: 2147287
    [No Abstract]   [Full Text] [Related]  

  • 31. Gene therapy for Down syndrome.
    Fillat C; Altafaj X
    Prog Brain Res; 2012; 197():237-47. PubMed ID: 22541296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships.
    Belichenko PV; Kleschevnikov AM; Salehi A; Epstein CJ; Mobley WC
    J Comp Neurol; 2007 Oct; 504(4):329-45. PubMed ID: 17663443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pitfalls and hopes in Down syndrome therapeutic approaches: in the search for evidence-based treatments.
    Dierssen M; Ortiz-Abalia J; Arqué G; de Lagrán MM; Fillat C
    Behav Genet; 2006 May; 36(3):454-68. PubMed ID: 16520905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes.
    Olson LE; Roper RJ; Baxter LL; Carlson EJ; Epstein CJ; Reeves RH
    Dev Dyn; 2004 Jul; 230(3):581-9. PubMed ID: 15188443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between genetic anomalies of different levels and deviations in dermatoglyphic traits. Part 4: Dermatoglyphic peculiarities of males and females with Down syndrome. Family study.
    Katznelson MB; Bejerano M; Yakovenko K; Kobyliansky E
    Anthropol Anz; 1999 Sep; 57(3):193-255. PubMed ID: 10584152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental instability of the cerebellum and its relevance to Down syndrome.
    Shapiro BL
    J Neural Transm Suppl; 2001; (61):11-34. PubMed ID: 11771737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A chromosome 21 critical region does not cause specific Down syndrome phenotypes.
    Olson LE; Richtsmeier JT; Leszl J; Reeves RH
    Science; 2004 Oct; 306(5696):687-90. PubMed ID: 15499018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Segmental trisomy of chromosome 17: a mouse model of human aneuploidy syndromes.
    Vacík T; Ort M; Gregorová S; Strnad P; Blatny R; Conte N; Bradley A; Bures J; Forejt J
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4500-5. PubMed ID: 15755806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene-dosage effect on chromosome 21 transcriptome in trisomy 21: implication in Down syndrome cognitive disorders.
    Kahlem P
    Behav Genet; 2006 May; 36(3):416-28. PubMed ID: 16557362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome.
    Siarey RJ; Villar AJ; Epstein CJ; Galdzicki Z
    Neuropharmacology; 2005 Jul; 49(1):122-8. PubMed ID: 15992587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.